Edwards Lifesciences Corp (EW)
70.38
+0.84
(+1.21%)
USD |
NYSE |
Nov 21, 16:00
70.39
+0.01
(+0.01%)
Pre-Market: 20:00
Edwards Lifesciences Debt to Equity Ratio: 0.0626 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.0626 |
June 30, 2024 | 0.0803 |
March 31, 2024 | 0.0839 |
December 31, 2023 | 0.0898 |
September 30, 2023 | 0.0896 |
June 30, 2023 | 0.0936 |
March 31, 2023 | 0.0998 |
December 31, 2022 | 0.1027 |
September 30, 2022 | 0.0959 |
June 30, 2022 | 0.1003 |
March 31, 2022 | 0.102 |
December 31, 2021 | 0.1021 |
September 30, 2021 | 0.1075 |
June 30, 2021 | 0.116 |
March 31, 2021 | 0.1278 |
December 31, 2020 | 0.1301 |
September 30, 2020 | 0.1413 |
June 30, 2020 | 0.1549 |
March 31, 2020 | 0.1524 |
December 31, 2019 | 0.1433 |
September 30, 2019 | 0.1558 |
June 30, 2019 | 0.1697 |
March 31, 2019 | 0.1723 |
December 31, 2018 | 0.1891 |
September 30, 2018 | 0.3551 |
Date | Value |
---|---|
June 30, 2018 | 0.3771 |
March 31, 2018 | 0.3249 |
December 31, 2017 | 0.3506 |
September 30, 2017 | 0.327 |
June 30, 2017 | 0.3459 |
March 31, 2017 | 0.3091 |
December 31, 2016 | 0.314 |
September 30, 2016 | 0.2231 |
June 30, 2016 | 0.2438 |
March 31, 2016 | 0.2619 |
December 31, 2015 | 0.2385 |
September 30, 2015 | 0.2498 |
June 30, 2015 | 0.2623 |
March 31, 2015 | 0.2722 |
December 31, 2014 | 0.2729 |
September 30, 2014 | 0.2919 |
June 30, 2014 | 0.3123 |
March 31, 2014 | 0.541 |
December 31, 2013 | 0.384 |
September 30, 2013 | 0.3702 |
June 30, 2013 | 0.1439 |
March 31, 2013 | 0.121 |
December 31, 2012 | 0.128 |
September 30, 2012 | 0.1142 |
June 30, 2012 | 0.129 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0626
Minimum
Sep 2024
0.1549
Maximum
Jun 2020
0.1088
Average
0.1021
Median
Debt to Equity Ratio Benchmarks
Teleflex Inc | 0.3924 |
Becton Dickinson & Co | 0.7761 |
NeuroOne Medical Technologies Corp | 0.00 |
SINTX Technologies Inc | 0.024 |
Nutriband Inc | 0.0158 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 12.97B |
Total Liabilities (Quarterly) | 3.360B |
Shareholders Equity (Quarterly) | 9.546B |
Current Ratio | 3.461 |
Net Debt Paydown Yield | -0.00% |